Inventor
ISKENDERIAN ANDREA
US5 patents
Patents
5 patentsUS9814764B2Nov 14, 2017
Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase
SHIRE HUMAN GENETIC THERAPIES9 citations90
US11065307B2Jul 20, 2021
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
SHIRE HUMAN GENETIC THERAPIES2 citations81
US10603364B2Mar 31, 2020
Lysosomal targeting and uses thereof
SHIRE HUMAN GENETIC THERAPIES2 citations70
US10722559B2Jul 28, 2020
Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
SHIRE HUMAN GENETIC THERAPIES5 citations68
US10729746B2Aug 4, 2020
Recombinant placenta growth factor for treating Duchenne muscular dystrophy
SHIRE HUMAN GENETIC THERAPIES0 citations49